- Home
- APGE vs VRNS Comparison
APGE vs VRNS Comparison
Compare APGE & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | VRNS |
|---|---|---|
| Founded | 2022 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.8B |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | APGE | VRNS |
|---|---|---|
| Price | $134.08 | $45.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 21 |
| Target Price | ★ $109.67 | $42.75 |
| AVG Volume (30 Days) | ★ 5.4M | 2.6M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $270,288,000.00 |
| Revenue This Year | N/A | $18.87 |
| Revenue Next Year | N/A | $17.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.35 |
| 52 Week Low | $34.34 | $19.70 |
| 52 Week High | $134.35 | $63.90 |
Technical Indicators
Market Signals| Indicator | APGE | VRNS |
|---|---|---|
| Relative Strength Index (RSI) | 80.75 | 62.93 |
| Support Level | $80.52 | $31.28 |
| Resistance Level | N/A | $49.54 |
| Average True Range (ATR) | 0.43 | 2.44 |
| MACD | -1.69 | -0.31 |
| Stochastic Oscillator | 86.53 | 49.75 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.